scholarly article | Q13442814 |
P356 | DOI | 10.1182/BLOOD.V99.4.1237 |
P698 | PubMed publication ID | 11830471 |
P50 | author | Allan Randrup Thomsen | Q30127185 |
Jan Pravsgaard Christensen | Q43182017 | ||
P2093 | author name string | Christina Bartholdy | |
Jeanette Erbo Christensen | |||
Anneline Nansen | |||
Susanne Ørding Andreasen | |||
P2860 | cites work | Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1237-1245 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | The role of CC chemokine receptor 5 in antiviral immunity | |
P478 | volume | 99 |
Q33908877 | Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2 |
Q45663708 | Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response |
Q40433578 | CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients |
Q27468933 | CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4+Foxp3+ T and IL-17+CD4+ Th17 cells |
Q36098944 | CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis |
Q38702121 | CCR5 blockade for neuroinflammatory diseases--beyond control of HIV. |
Q97550828 | CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation |
Q37358025 | CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality |
Q24646031 | Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection |
Q58064957 | Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals |
Q36981179 | Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection |
Q34761117 | Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia. |
Q34059483 | Defining the chemokine basis for leukocyte recruitment during viral encephalitis |
Q42984759 | Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia. |
Q43023517 | Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia. |
Q47581613 | Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. |
Q35209368 | Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function |
Q45722206 | Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system |
Q35634901 | Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence |
Q28188558 | HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors |
Q50351898 | Identification of Shared Molecular Signatures Indicate the Susceptibility of Endometriosis to Multiple Sclerosis |
Q37287603 | Influence of the CCR-5/MIP-1 α axis in the pathogenesis of Rocio virus encephalitis in a mouse model |
Q35048826 | Knock out models to dissect chemokine receptor function in vivo |
Q63246385 | Local Antigen Encounter Is Essential for Establishing Persistent CD8 T-Cell Memory in the CNS |
Q37175343 | Lymphocytic choriomeningitis infection of the central nervous system |
Q37267001 | Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organ |
Q37101154 | Multistrain genetic comparisons reveal CCR5 as a receptor involved in airway hyperresponsiveness |
Q40639381 | Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection |
Q37678456 | Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report |
Q36944914 | RNA interference and antiviral therapy. |
Q35044766 | Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines |
Q44394482 | Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression |
Q27490393 | Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection |
Q40133015 | Role of macrophage inflammatory protein-1alpha in T-cell-mediated immunity to viral infection |
Q35149275 | Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages |
Q27477986 | The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source |
Q34427503 | The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis |
Q36606525 | The expression of the chemokine receptor CCR5 in tick-borne encephalitis. |
Q34726185 | The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection |
Q35960061 | The role of CCR5 in HCV infection |
Q35149350 | The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation |
Q34362854 | Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5. |
Q33642954 | α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets. |
Search more.